- Report
- April 2024
- 80 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1365EUR$1,500USD£1,170GBP
- Report
- June 2022
- 162 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- October 2024
- 95 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2024
- 86 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2022
- 115 Pages
Global
From €3145EUR$3,456USD£2,696GBP
The Implantable Cardiac Monitor (ICM) is a type of cardiovascular device used to monitor the electrical activity of the heart. It is implanted directly into the patient's chest and is used to detect arrhythmias, or abnormal heart rhythms. The device is designed to detect and record changes in the heart's electrical activity, which can be used to diagnose and treat cardiac conditions. ICMs are typically used in patients with a history of arrhythmias or those at risk of developing them.
The ICM market is a rapidly growing segment of the cardiovascular device industry. It is driven by the increasing prevalence of cardiovascular diseases, the growing demand for advanced monitoring solutions, and the development of new technologies. ICMs are becoming increasingly popular due to their ability to provide continuous monitoring and early detection of cardiac conditions.
Some of the major players in the ICM market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more